» Articles » PMID: 39009587

Single-cell Transcriptomics Analysis of Bullous Pemphigoid Unveils Immune-stromal Crosstalk in Type 2 Inflammatory Disease

Overview
Journal Nat Commun
Specialty Biology
Date 2024 Jul 15
PMID 39009587
Authors
Affiliations
Soon will be listed here.
Abstract

Bullous pemphigoid (BP) is a type 2 inflammation- and immunity-driven skin disease, yet a comprehensive understanding of the immune landscape, particularly immune-stromal crosstalk in BP, remains elusive. Herein, using single-cell RNA sequencing (scRNA-seq) and in vitro functional analyzes, we pinpoint Th2 cells, dendritic cells (DCs), and fibroblasts as crucial cell populations. The IL13-IL13RA1 ligand-receptor pair is identified as the most significant mediator of immune-stromal crosstalk in BP. Notably, fibroblasts and DCs expressing IL13RA1 respond to IL13-secreting Th2 cells, thereby amplifying Th2 cell-mediated cascade responses, which occurs through the specific upregulation of PLA2G2A in fibroblasts and CCL17 in myeloid cells, creating a positive feedback loop integral to immune-stromal crosstalk. Furthermore, PLA2G2A and CCL17 contribute to an increased titer of pathogenic anti-BP180-NC16A autoantibodies in BP patients. Our work provides a comprehensive insight into BP pathogenesis and shows a mechanism governing immune-stromal interactions, providing potential avenues for future therapeutic research.

Citing Articles

Bullous pemphigoid.

Akbarialiabad H, Schmidt E, Patsatsi A, Lim Y, Mosam A, Tasanen K Nat Rev Dis Primers. 2025; 11(1):12.

PMID: 39979318 DOI: 10.1038/s41572-025-00595-5.


Associated factors related to production of autoantibodies and dermo-epidermal separation in bullous pemphigoid.

Yang L, Wang Y, Zuo Y Arch Dermatol Res. 2025; 317(1):303.

PMID: 39853516 DOI: 10.1007/s00403-024-03760-0.


IL-27 as a novel biomarker for pruritus in nodular prurigo and bullous pemphigoid.

Wang Y, Zhang X, Teng Y, Shen C Front Immunol. 2024; 15:1499868.

PMID: 39735535 PMC: 11681427. DOI: 10.3389/fimmu.2024.1499868.

References
1.
Kridin K, Ludwig R . The Growing Incidence of Bullous Pemphigoid: Overview and Potential Explanations. Front Med (Lausanne). 2018; 5:220. PMC: 6109638. DOI: 10.3389/fmed.2018.00220. View

2.
Ma F, Gharaee-Kermani M, Tsoi L, Plazyo O, Chaskar P, Harms P . Single-cell profiling of prurigo nodularis demonstrates immune-stromal crosstalk driving profibrotic responses and reversal with nemolizumab. J Allergy Clin Immunol. 2023; 153(1):146-160. PMC: 11231883. DOI: 10.1016/j.jaci.2023.07.005. View

3.
He H, Suryawanshi H, Morozov P, Gay-Mimbrera J, Del Duca E, Kim H . Single-cell transcriptome analysis of human skin identifies novel fibroblast subpopulation and enrichment of immune subsets in atopic dermatitis. J Allergy Clin Immunol. 2020; 145(6):1615-1628. DOI: 10.1016/j.jaci.2020.01.042. View

4.
Gegotek A, Domingues P, Wronski A, Skrzydlewska E . Changes in Proteome of Fibroblasts Isolated from Psoriatic Skin Lesions. Int J Mol Sci. 2020; 21(15). PMC: 7432102. DOI: 10.3390/ijms21155363. View

5.
Murrell D, Daniel B, Joly P, Borradori L, Amagai M, Hashimoto T . Definitions and outcome measures for bullous pemphigoid: recommendations by an international panel of experts. J Am Acad Dermatol. 2011; 66(3):479-85. PMC: 3883429. DOI: 10.1016/j.jaad.2011.06.032. View